Sudarshan Jain

Sudarshan Jain is a member of the 2022 Expert Review Committee for the Generic & Biosimilar Medicines Programme. He is also a member of the Expert Committee for the 2020 Antimicrobial Resistance Benchmark. Sudarshan is currently the Secretary General of Indian Pharmaceutical Alliance (IPA), Senior Advisor with APAX Partners and is a Board member of multiple organisations.

Sudarshan brings over 40 years’ experience in field force management, brand building and overall business operations in healthcare companies covering Pharmaceutical, OTC, Hospital, Diagnostic and Nutrition businesses. He has held several leadership positions including in Abbott, Johnson & Johnson and a number of Indian pharmaceutical companies. Sudarshan has also served as Vice President of Organization of Pharmaceuticals Producers of India (OPPI) representing research- based pharmaceutical companies.

Sudarshan is currently the member of the Board of Abbott India, Healthium Limited (APAX portfolio company), Zandu Chemicals Limited, PharmEasy, Indian Institute of Health Management Research, Jaipur, member of the Advisory Board of Narsee Monjee University, Mumbai (NMIMS), Board Member of Indian Education Society (IES) and Charter Member of The Indus Entrepreneurs, Mumbai (TiE). Sudarshan is the first Indian recipient of the Global Chairman’s Award at Abbott and has also contributed in shaping the healthcare policy and improving access to healthcare in India. Sudarshan is an alumni of St. Stephens College, Delhi and Indian Institute of Management, Ahmedabad.